First Time Loading...

Gan & Lee Pharmaceuticals
SSE:603087

Watchlist Manager
Gan & Lee Pharmaceuticals Logo
Gan & Lee Pharmaceuticals
SSE:603087
Watchlist
Price: 50.33 CNY -1.37% Market Closed
Updated: May 9, 2024

Wall Street
Price Targets

Price Targets Summary
Gan & Lee Pharmaceuticals

Wall Street analysts forecast Gan & Lee Pharmaceuticals stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Gan & Lee Pharmaceuticals is 63.24 CNY with a low forecast of 62.62 CNY and a high forecast of 65.1 CNY.

Lowest
Price Target
62.62 CNY
24% Upside
Average
Price Target
63.24 CNY
26% Upside
Highest
Price Target
65.1 CNY
29% Upside
Gan & Lee Pharmaceuticals Competitors:
Price Targets
IONS
Ionis Pharmaceuticals Inc
41% Upside
300009
Anhui Anke Biotechnology Group Co Ltd
86% Upside
AURA
Aura Biosciences Inc
173% Upside
MNKD
MannKind Corp
64% Upside
VCEL
Vericel Corp
15% Upside
GNFT
Genfit SA
181% Upside
MYGN
Myriad Genetics Inc
2% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
7% Upside

Revenue
Forecast

Revenue Estimate
Gan & Lee Pharmaceuticals

For the last 4 years the compound annual growth rate for Gan & Lee Pharmaceuticals's revenue is -8%. The projected CAGR for the next 3 years is 40%.

-8%
Past Growth
40%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Gan & Lee Pharmaceuticals

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Gan & Lee Pharmaceuticals

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Gan & Lee Pharmaceuticals's stock price target?
Price Target
63.24 CNY

According to Wall Street analysts, the average 1-year price target for Gan & Lee Pharmaceuticals is 63.24 CNY with a low forecast of 62.62 CNY and a high forecast of 65.1 CNY.

What is Gan & Lee Pharmaceuticals's Revenue forecast?
Projected CAGR
40%

For the last 4 years the compound annual growth rate for Gan & Lee Pharmaceuticals's revenue is -8%. The projected CAGR for the next 3 years is 40%.